High-Content Cell-Based Screening (Biophenics)

Access specialist infrastructure, technologies and expert teams without building them internally.

Scientific visual associated with High-Content Cell-Based Screening (Biophenics)
Platforms expertise — Curie Cancer
01Carnot instituteCurie Cancer
02Development stageDiscovery / target validation
03Main expertisePlatforms
04Relevant fieldsAll fields

Offer overview

What this offer helps you achieve

Access specialist infrastructure, technologies and expert teams without building them internally.

Scientific and technical scope

BioPhenics provides research teams with the technical resources and expertise needed to carry out customized High-Content Screening (HCS) as well as multi-parametric high content imaging assays and biochemical cellular screening. BioPhenics uses automated fluorescent microscopy imaging technology for phenotypic characterization of small-molecule and siRNAs effects on cellular systems to identify novel compounds that modulate targeted pathways.
01

Capabilities mobilised

Therapeutic areasExpert adviceTherapeutic target discoveryPlatforms
02

Application fields

All fields

Discuss this offer

Could this capability strengthen your R&D programme?

Present your scientific, technical or clinical need and identify the most relevant route to collaboration.